A growing shift toward artificial intelligence in personal lines insurance is reshaping how claims are processed, raising concerns about accuracy, fairness, and the potential consequences for patients and policyholders.
In 2026, insurers across health, home, and auto segments are increasingly relying on automated systems to evaluate claims, replacing or supplementing human adjusters. While the approach promises efficiency, it has introduced new uncertainties, particularly when automated decisions hinge on rigid data inputs and system logic.
Automation in Claims Processing and Its Consequences
In traditional systems, a straightforward medical claim, such as a rapid strep test, would typically be reviewed and approved by a human adjuster based on clear medical necessity. Under AI-driven systems, however, outcomes may depend heavily on how data is submitted and interpreted by automated models.
Errors in forms, technical inconsistencies, or flaws within the AI system itself can lead to automatic denials. Insurance companies, which use complex models to manage claim volumes and limit financial exposure, are increasingly deploying such tools to tighten approval processes.
By 2023, nearly 88 percent of auto insurers were using or planning to use AI in claims processing. A survey across 16 states found that 84 percent of US health insurers were already using AI for functions such as prior authorization for medical care.
FCRF Launches Premier CISO Certification Amid Rising Demand for Cybersecurity Leadership
Patient Experiences and Growing Pushback
Cases emerging from early implementations highlight the human impact of automated decision-making. Iris Smith, an 80-year-old Florida resident with arthritis, was identified in an investigation as a potential victim of AI-driven preauthorization denials in a state exploring AI-based Medicare screening programs.
Smith described frustration with decisions made by automated systems, emphasizing her reliance on her doctors’ judgment for managing chronic pain. Florida representative Lois Frankel has opposed the expansion of such programs, arguing that medical care decisions should remain guided by physicians rather than automated systems.
Critics warn that replacing human oversight with automated processes risks undermining patient care, particularly when systems fail to account for individual circumstances.
Regulatory Gaps and Industry Concerns
The expansion of AI in insurance is unfolding in a regulatory environment that remains uneven. Currently, 22 states have not adopted specific regulations governing the use of AI in underwriting.
Observers note that states serve as a key line of defense for consumers, but the lack of consistent oversight has raised broader concerns about accountability within the industry. The growing reliance on automation is seen by some as exacerbating existing pressures in the health insurance system, where access to care is already constrained.
As insurers continue to integrate AI into their operations, the debate over efficiency versus fairness is expected to intensify, with policymakers, industry leaders, and patients closely watching how these systems shape access to essential services.
